|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development | |||||
| General and administrative | |||||
| Operating loss | |||||
| Financial Income (expenses), net | |||||
| Loss after | |||||
| Other Income | |||||
| Net loss | |||||
| Non-controlling interests | |||||
| Net loss attributable to equity holders of the Company | |||||
| Basic net loss per share attributable to equity holders of the Company | |||||
| Diluted net loss per share attributable to equity holders of the Company | |||||
| Weighted average number of ordinary shares used in computing basic loss per share | |||||
| Weighted average number of ordinary shares used in computing diluted loss per share | |||||
Loading...